You are here Home Guidance and resources Publications hub Scheduling submissions Public submissions on interim decisions for scheduling matters referred to the ACMS #38, ACCS #34 and Joint ACMS-ACCS #31 held in June 2022 (including MDMA and psilocybine) Published 3 February 2023 Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Public submissions on interim decisions for scheduling matters referred to the ACMS #38, ACCS #34 and Joint meetings for ACCS-ACMS #31 (except MDMA and psilocybine), June 2022 Public submissions on interim decisions for scheduling matters (MDMA and psilocybine) referred to the ACMS #38, June 2022 Topics Advisory bodies and committees Scheduling (national classification system) Outcome of Advisory Committee on Medicines Scheduling (ACMS) Advisory Committee on Chemicals Scheduling (ACCS) ACMS #38, June 2022 ACCS #34, June 2022 Joint ACMS-ACCS meeting #31, June 2022